OptMed(OMED)

0.8900 0.0000 0.0%

今开:0.0昨收:0.89
最高:0.0 最低:0.0
涨停价:0.0跌停价:0.0
总市值:3.4434179E7

OptMed的最新讨论

从VEGF/DLL4双抗“三兄弟”的前世今生,分析双抗研发策略

同写意2022-05-14 21:40

撰文丨顾津明,同润生物CSO
编辑丨于靖
近日,Compass Therapeutics公布了其VEGF/DLL4(CTX-009)双特异抗体联合紫杉醇在治疗胆道癌(BTC)的2期临床中期研究成果,结果表明该双抗药物安全性良好,在24名患者中有10位病人平均治疗6个月后得到了客观缓解,ORR为42%(10/24),算不上惊艳,...查看全文

Horned_Reaper2019-03-09 00:21

$Oncomed制药(OMED)$ 0.848加点仓,希望可以像SEEL一样起飞查看全文

Horned_Reaper2019-02-28 05:25

$Oncomed制药(OMED)$ 看来要再洗掉几层皮!航班开始无限期延误...[好困惑]查看全文

Horned_Reaper2019-02-21 05:51

$Oncomed制药(OMED)$ 看来飞机超载,要洗一洗才能起飞[滴汗]查看全文

Horned_Reaper2019-02-16 02:56

$Oncomed制药(OMED)$ 晚了一点起飞[加油]查看全文

Horned_Reaper2019-01-07 22:55

$Oncomed制药(OMED)$ 请收起小桌板,调直座椅靠背,系好安全带!查看全文

Horned_Reaper2019-01-04 23:35

$Oncomed制药(OMED)$ 随时要起飞的节奏…查看全文

usbiostock2018-08-03 09:49

$OncoMed Pharmaceuticals, Inc. (OMED)$ 1. Navicixizumab单药治疗实体瘤临床1a期试验一线数据预计:2018年第4季度;2. Etigilimab单药治疗进展性/转移性实体瘤临床1a期试验一线数据预计:2018年第4季度;3. 现金:$79.9M。查看全文

1 2 3

OptMed的公告

$ONCOMED PHARMACEUTICALS INC(OMED)$ 8-K - Current report Filed: 2016-12-06 AccNo: 0001564590-16-029871 Size: 26 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers http:...

$ONCOMED PHARMACEUTICALS INC(OMED)$ 内部交易: 2016-11-16,SVP, Cancer Biology & Co-CSO,Hoey Timothy ,卖出,12500普通股, $9.89

$ONCOMED PHARMACEUTICALS INC(OMED)$ 内部交易: 2016-11-16,SVP, Cancer Biology & Co-CSO,Hoey Timothy ,期权,12500普通股, $1.43

$ONCOMED PHARMACEUTICALS INC(OMED)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2016-11-01 AccNo: 0001564590-16-026741 Size: 5 MB 网页链接

$ONCOMED PHARMACEUTICALS INC(OMED)$ 8-K - Current report Filed: 2016-11-01 AccNo: 0001564590-16-026728 Size: 238 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接

$ONCOMED PHARMACEUTICALS INC(OMED)$ 美东时间 2016-11-01 16:30 After Market Close:ONCOMED PHARMA Earning Release . Wall St EPS Est ($):-0.73. 网页链接

$ONCOMED PHARMACEUTICALS INC(OMED)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2016-08-26 AccNo: 0000921895-16-005592 Size: 230 KB 网页链接

$ONCOMED PHARMACEUTICALS INC(OMED)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2016-08-24 AccNo: 0001571049-16-017694 Size: 56 KB 网页链接

$ONCOMED PHARMACEUTICALS INC(OMED)$ 8-K - Current report Filed: 2016-08-23 AccNo: 0001193125-16-688706 Size: 204 KBItem 1.01: Entry into a Material Definitive AgreementItem 9.01: Financial Statements and Exhibits 网页链接

$ONCOMED PHARMACEUTICALS INC(OMED)$ 424B5 - Prospectus [Rule 424(b)(5)] Filed: 2016-08-19 AccNo: 0001193125-16-686553 Size: 403 KB 网页链接

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36